Trial
NCT03438344
Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Reducing CMV Related Complications in Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
City of Hope Medical Center
Collaborators
—
Condition
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Intervention
Multi-antigen CMV-Modified Vaccinia Ankara Vaccine
Why stopped
PI Withdrawal
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-11-21